aod9604 titan medical Achieves First Medtronic Milestone Titan Medical shows off Enos

5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that plays a central role in NAD+ metabolism and cellular energy balance

The other three treatment groups were represented approximately equally in the largest cluster, with a maximum of one animal per treatment group outside the cluster

Early studies indicated that the peptide might stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) in preclinical settings

How often we test depends on the patients health and how they react to treatment

Here are two of the most notable experiments to date: In an 11-day study, obese mice treated with 20mg/kg of 5-amino-1MQ trice daily experienced a 5.1% weight reduction from baseline, while control mice gained 1.4% in body weight

Treatment goal: Reduce or eliminate the need for red blood cell transfusions